Replies to post #177181 on Biotech Values

[DewDiligence]

Wall Street is in a market-manipulation business rather than in investment. Their "perception" that in "a long run" MRK will be a number two player in HCV has no substance.

Let’s not paint with too broad a brush! Not every Wall Street analyst thinks MRK will end up as the #2 player in HCV; to the contrary, the analysts who think that are in the distinct minority, as far as I can tell.